ClinicalTrials.govpublic full text
A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV
respiratory syncytial virus infections, human respiratory syncytial virus, phase i, recombinant bcg vaccine, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1046608
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.